v3.26.1
Statements of Cash Flows - USD ($)
 4 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Cash Flows from Operating Activities:    
Net income (loss) $ (15,209) $ 3,473,428
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (4,543,241)
Payment of operation costs through IPO Promissory Note – related party 37,574
Changes in operating assets and liabilities:    
Prepaid expenses (87,382)
Due from Sponsor (550)
Long-term prepaid insurance (16,517)
Accrued expenses 15,209 315,822
Net cash used in operating activities (820,866)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (144,181,250)
Net cash used in investing activities (144,181,250)
Cash Flows from Financing Activities:    
Proceeds from sale of Public Units, net of underwriting discounts paid 140,875,000
Proceeds from sale of Private Placement Units 5,656,250
Repayment of IPO Promissory Note – related party (162,616)
Payment of offering costs (273,309)
Net cash provided by financing activities 146,095,325
Net Change in Cash 1,093,209
Cash – Beginning of period
Cash – End of period 1,093,209
Non-cash investing and financing activities:    
Offering costs included in accrued offering costs 17,500 62,500
Offering costs paid through IPO Promissory Note – related party 12,500
Offering costs paid in exchange of issuance of Class B Ordinary Shares 25,000
Deferred offering costs paid through IPO Promissory Note – related party 112,542
Deferred Fee payable $ 5,031,250